In the field of gene therapy, CRISPR-Cas9 and other cutting-edge gene editing technologies are being employed to knock out or silence the NLRC3 gene, aiming to enhance the immune system's ability to recognize and eliminate tumor cells. The gene discussed is NLRC3; the disease is neoplasm.